FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
FDA and USDA among federal agencies aiming to rehire workers hit by mass firings
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...
Smokescreen: some vape firms pivot after FDA crackdown
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
Morningstar4d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...
Toronto Star4d
FDA moves to rehire medical device staffers fired only days earlier
Associated Press (AP) — Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back.
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Hosted on MSN4h
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More
Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.